171 293

Cited 3 times in

옥살리플라틴 유도 말초신경독성 측정도구의 고찰

Other Titles
 Properties of the Measures to Assess Oxaliplatin-induced Peripheral Neuropathy: A Literature Review 
Authors
 추상희  ;  이윤주  ;  이영주  ;  Cleeland, Charles S 
Citation
 JOURNAL OF KOREAN ACADEMY OF NURSING, Vol.45(6) : 783-801, 2015 
Journal Title
 JOURNAL OF KOREAN ACADEMY OF NURSING 
ISSN
 2005-3673 
Issue Date
2015
MeSH
Activities of Daily Living ; Antineoplastic Agents/adverse effects* ; Antineoplastic Agents/therapeutic use ; Databases, Factual ; Humans ; Neoplasms/drug therapy ; Organoplatinum Compounds/adverse effects* ; Organoplatinum Compounds/therapeutic use ; Peripheral Nervous System Diseases/etiology* ; Psychometrics
Keywords
Oxaliplatin ; Peripheral nervous system diseases ; Symptom assessment ; Psychometrics
Abstract
PURPOSE: The purpose of this study is to provide a comprehensive overview of the various measures available for assessment of oxaliplatin-induced peripheral neuropathy (OXLIPN) and to evaluate the measurement properties of each assessment tool. METHODS: A systematic review was conducted to identify existing measures for OXLIPN found in the databases of PubMed, Cochrane Library, Embase, RISS and KoreaMed. The quality of the 24 identified tools was evaluated based on their properties of measurement including content validity, internal consistency, criterion validity, construct validity, reproducibility, responsiveness, floor-ceiling effects and interpretability. RESULTS: Ten (41.7%) of the 24 tools were identified as specific measures for assessing OXLIPN and the most popular type of measures were clinical grading systems by clinicians (58.3%) and only 29.2% of measures were identified as patient reported outcomes. The most frequently used tool was National Cancer Institute-Common Toxicity Criteria (NCI-CTC), but the validity of NCI-CTC has not been reported appropriately. Overall, the Neuropathic Pain Symptom Inventory (NPSI) received the best psychometric scores, and the Chemotherapy-induced Peripheral Neuropathy Assessment Tool (CIPNAT) and Functional Assessment of Cancer Therapy/Gynaecologic Oncology Group-neurotoxicity-12 (FACT/GOG-Ntx-12) followed NPSI. CONCLUSION: To select appropriate measure, evidences should be accumulated through the clinical use of tools. Therefore, practitioner and researchers are urged to report relevant statistics required for the validation of the currently used measures for assessment of OXLIPN.
Files in This Item:
T201505223.pdf Download
DOI
10.4040/jkan.2015.45.6.783
Appears in Collections:
5. Research Institutes (연구소) > Others (기타) > 1. Journal Papers
3. College of Nursing (간호대학) > Dept. of Nursing (간호학과) > 1. Journal Papers
Yonsei Authors
Lee, Young Joo(이영주)
Chu, Sang Hui(추상희) ORCID logo https://orcid.org/0000-0001-6877-5599
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/157064
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links